GlassScriptPhysician profile
Nasser D Askari
NPI 1508112582
$429.67
in general payments reported to CMS, 2019-2025
11 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.87 · 2021: $20.34 · 2023: $74.69 · 2024: $117 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $102.17 | 2023-2024 | Avvigo Guidance System, Opticross, Lux-Dx Insertable Cardiac Monitor |
| Glaxosmithkline, LLC. | $97.98 | 2025 | Trelegy Ellipta |
| Novo Nordisk INC | $38.53 | 2024 | Rybelsus, Ozempic |
| Abbott Laboratories | $34.45 | 2021-2024 | Proclaim |
| Astrazeneca Pharmaceuticals LP | $32.66 | 2024-2025 | Breztri |
| Pfizer INC. | $26.87 | 2025 | |
| Sumitomo Pharma America, INC. | $22.27 | 2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $22.24 | 2024 | Spravato |
| Lilly USA, LLC | $22.00 | 2025 | Jardiance |
| Exact Sciences Corporation | $18.63 | 2025 | Cologuard Collection Kit |
| Cranial Technologies, INC | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nasser Askari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.